Audacy Announces Multi-Platform Partnership with Genomind

RADIO ONLINE | Monday, May 3, 2021

Audacy

Audacy has announced a multiplatform partnership with mental health company Genomind. The partnership taps into Audacy's influencers and Genomind's personalized genetic insights to bring mental health conversations into the mainstream.

As part of the partnership, Audacy will utilize the local connection of 15 stations across eight markets -- Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington DC -- to promote Genomind's new Mental Health Map, a consumer DNA test to offer a a blueprint of the genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior and eating behavior.

Audacy and Genomind are aligning in this shared commitment to end the stigma surrounding mental health. Audacy's voices and influencers will serve as ambassadors for the campaign -- sharing their first hand experiences, using the Mental Health Map to learn more about their genetic makeup and predispositions toward mental health and wellness traits. Audacy is also among the first to provide Genomind as an employee benefit to help drive more engagement and action in mental health and wellness.

"Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we're excited to further activate our commitment through this partnership with Genomind," said Audacy VP/Social Impact Sarah Harris. "We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind's mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health."

"Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness," added Genomind President Kip Olmstead. "Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy's leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner."

Genomind will also serve as the sponsor for Audacy's "I'm Listening Daily Capsules," 60-second daily public service announcements as part of the company's yearlong "I'm Listening" mental health initiative. Genomind will also serve as the presenting sponsor of Audacy's annual "I'm Listening" broadast, a live national program that brings together artists, athletes and medical specialists every September to remind listeners it's okay to not be okay, raise awareness and end the stigma of talking about mental health.